Catherine Calarco is a proven CEO with a track record of scaling companies, launching award-winning technologies, and driving revenue growth in AI, MedTech, and women’s health. With experience at Thermo Fisher/Biolab, Automation Anywhere, and HeartMath, she has increased revenues from $10M to $400M and played a key role in scaling Automation Anywhere at a $6.8B valuation.
Catherine is a Board Director at Optomed Plc, a leader in AI-powered vision screening. She has raised millions in capital, secured strategic partnerships with companies like Kaiser, and driven product innovation in women’s health. Catherine has also advised Nerbio and MIT startups on market expansion and fundraising. Her expertise in AI, MedTech, and regulatory strategy drives impactful growth and acquisition.
As a Senior Lecturer and MBA at MIT Sloan School of Management, Catherine advised CEOs on scaling profitable growth. A renowned speaker, she hosts the "Humanity Evolve" radio show. An advocate for women’s leadership, Catherine is a member of the Exceptional Women’s Alliance, Avante Capital WON, and Astia.org.